Cargando…

Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation

The emergence of resistance to imatinib mediated by mutations in the BCR-ABL has become a major challenge in the treatment of chronic myeloid leukemia (CML). Alternative therapeutic strategies to override imatinib-resistant CML are urgently needed. In this study, we investigated the effect of AKI603...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Le-Xun, Wang, Jun-Dan, Chen, Jia-Jie, Long, Bing, Liu, Ling-Ling, Tu, Xi-Xiang, Luo, Yu, Hu, Yuan, Lin, Dong-Jun, Lu, Gui, Long, Zi-Jie, Liu, Quentin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099696/ https://www.ncbi.nlm.nih.gov/pubmed/27824120 http://dx.doi.org/10.1038/srep35533

Ejemplares similares

A Novel Aurora Kinase Inhibitor Attenuates Leukemic Cell Proliferation Induced by Mesenchymal Stem Cells
por: Wang, Jun-Dan, et al.
Publicado: (2020)

T315I-mutated myeloid sarcoma
por: Zhang, Yumeng, et al.
Publicado: (2019)

Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
por: Pan, Xiao-Na, et al.
Publicado: (2014)

Target Inhibition of CBP Induced Cell Senescence in BCR-ABL- T315I Mutant Chronic Myeloid Leukemia
por: Yang, Ke, et al.
Publicado: (2021)

Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation
por: Sun, Yuening, et al.
Publicado: (2022)

Primate-specific miR-603 is implicated in the risk and pathogenesis of Alzheimer's disease
por: Zhang, Chi, et al.
Publicado: (2016)

R603 status and vector meson studies ($\rhô^{0} and \phi^{0}$) with the R603
por: Lockman, W, et al.
Publicado: (1974)

Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
por: Lu, Ying, et al.
Publicado: (2016)

Inhibition of mitotic kinase Aurora suppresses Akt-1 activation and induces apoptotic cell death in all-trans retinoid acid-resistant acute promyelocytic leukemia cells
por: Xu, Duo-Rong, et al.
Publicado: (2011)

Aurora kinase A suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells
por: Xu, Ling-Zhi, et al.
Publicado: (2014)

Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation
por: Okabe, Seiichi, et al.
Publicado: (2015)

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
por: Giudice, Valentina, et al.
Publicado: (2020)

The rate of acute kidney injury (AKI) alert detection by the attending physicians was associated with the prognosis of patients with AKI
por: Shi, Yu, et al.
Publicado: (2022)

Status report of R603 and request for continuation
por: CERN. Geneva. ISR Experiments Committee
Publicado: (1974)

Observations relative to R603 Experimental Magnet
por: Lemeilleur, F
Publicado: (1974)

STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
por: Huang, Ze-Wei, et al.
Publicado: (2023)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5
por: Dong, Xianghua, et al.
Publicado: (2021)

Inhibition of BRD4 triggers cellular senescence through suppressing aurora kinases in oesophageal cancer cells
por: Xu, Jian‐Ling, et al.
Publicado: (2020)

603 Infections in Patients Diagnosed with Common Variable Immunodeficiency
por: Köse, Sükran, et al.
Publicado: (2012)

SAT-603 Graves' Disease and an Anterior Mediastinal Mass
por: Robbins, D'lorah, et al.
Publicado: (2019)

603. Comparing assays for Clinical Phage Microbiology in biofilm
por: Rimon, Amit, et al.
Publicado: (2022)

Nicotinamide Mononucleotide Attenuates Renal Interstitial Fibrosis After AKI by Suppressing Tubular DNA Damage and Senescence
por: Jia, Yan, et al.
Publicado: (2021)

Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy
por: Zhou, Lu, et al.
Publicado: (2019)

Reviewers BJCVS 31.5
Publicado: (2016)

Health Tract No. 315: Presentiments
Publicado: (1868)

P673: ASCIMINIB MANAGMENT IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH T315I MUTATION.
por: Kuzmina, Elena, et al.
Publicado: (2023)

Experiment R603 in place at intersection I6, ISR
por: CERN PhotoLab
Publicado: (1973)

PT603. The contribution of resveratrol to the antiepileptic effects of diazepam and gabapentin
por: Kaygısız, B, et al.
Publicado: (2016)

Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival
por: Yao, Jin-e, et al.
Publicado: (2009)

Comparison between acute kidney injury (AKI) and non‐AKI patients secondary to severe hypothyroidism
por: Han, Bing, et al.
Publicado: (2018)

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia
por: Wang, Huafeng, et al.
Publicado: (2022)

Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A
por: Xu, Yun, et al.
Publicado: (2023)

Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia
por: Yusoff, Yuslina Mat, et al.
Publicado: (2018)

Performance of the renal resistive index and usual clinical indicators in predicting persistent AKI
por: Fu, You, et al.
Publicado: (2022)

Serum uric acid and AKI: is it time?
por: Kaushik, Manish, et al.
Publicado: (2016)

Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation
por: Jiang, Liang, et al.
Publicado: (2021)

Front part of the spectrometer installed in I6 : experiment R603
por: CERN PhotoLab
Publicado: (1973)

Beam Loss and Collimation at LHC, CERN-LHC-Project-Report-603
por: Jeanneret, J B, et al.
Publicado: (2002)

Correction to Lancet Glob Health 2017; 5: e593–603
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_944ubvhrt43oqgpkope1h5q29c